168 related articles for article (PubMed ID: 29728404)
1. Oral arsenic and all-
Zhu HH; Liu YR; Jia JS; Qin YZ; Zhao XS; Lai YY
Blood; 2018 Jun; 131(26):2987-2989. PubMed ID: 29728404
[No Abstract] [Full Text] [Related]
2. Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.
Zhu HH; Huang XJ
N Engl J Med; 2014 Dec; 371(23):2239-41. PubMed ID: 25470713
[No Abstract] [Full Text] [Related]
3. Arsenic in the treatment of newly diagnosed acute promyelocytic leukemia: current status and future research direction.
Hu J
Front Med; 2011 Mar; 5(1):45-52. PubMed ID: 21681674
[TBL] [Abstract][Full Text] [Related]
4. Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA).
Hogan CJ; Wiley JS; Billington T
Aust N Z J Med; 1997 Aug; 27(4):450-1. PubMed ID: 9448894
[No Abstract] [Full Text] [Related]
5. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
[TBL] [Abstract][Full Text] [Related]
6. The simpler, the better: oral arsenic for acute promyelocytic leukemia.
Zhu HH; Hu J; Lo-Coco F; Jin J
Blood; 2019 Aug; 134(7):597-605. PubMed ID: 31113776
[TBL] [Abstract][Full Text] [Related]
7. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
8. Tretinoin for the treatment of acute promyelocytic leukemia.
Wu H
Cancer Pract; 2002; 10(2):109-11. PubMed ID: 11903277
[No Abstract] [Full Text] [Related]
9. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ
Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413
[No Abstract] [Full Text] [Related]
11. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of the therapeutic effects and reactions in treating acute promyelocytic leukemia with intravenous arsenic trioxide or all-trans retinoic acid].
Zhang X; Yang L; Qiao Z
Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):113-5. PubMed ID: 11798639
[TBL] [Abstract][Full Text] [Related]
13. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Asou N
Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
[No Abstract] [Full Text] [Related]
14. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary embolism in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Jiménez-Yuste V; Martín MP; Canales M; Ojeda E; Hernández-Navarro F
Leukemia; 1997 Nov; 11(11):1988-9. PubMed ID: 9369438
[No Abstract] [Full Text] [Related]
16. Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia.
Mourad YA; Jabr F; Salem Z
Int J Dermatol; 2005 Jan; 44(1):68-9. PubMed ID: 15663666
[TBL] [Abstract][Full Text] [Related]
17. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
[No Abstract] [Full Text] [Related]
18. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
19. [Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].
de Thé H
Bull Acad Natl Med; 1998; 182(1):63-71. PubMed ID: 9622932
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid in acute promyelocytic leukemia.
Sanz MA; Martín G; Díaz-Mediavilla J
N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
